Almost one hundred people, many of them key players in the industry, attended the NautaDutilh Life Sciences Seminar we organised at our Amsterdam office last Thursday. Together with representatives from the US and UK law firm Goodwin and NautaDutilh, they discussed this year's theme Challenges and opportunities in Europe and the USA.
Also on the program: a panel discussion - moderated by Het Financieele Dagblad journalist Thieu Vaessen - on the affordability of medicines, featuring Marc Pomp (health economist), Jacquelien Noordhoek (Director Netherlands Cystic Fibrosis Foundation), John de Koning (Life Sciences Partners) and Wilbert Bannenberg (Chairman Pharmaceutical Accountability Foundation). During the workshops topics such as 'EU challenges to pharmaceutical product liability' and 'Funding and exits: an exploration of alternative models' were discussed. The event was concluded by seasoned PR advisor Jeroen van Seeters who gave an inspirational crash course on reputation and perception.
Looking back on the seminar, Ruud Smits - partner at NautaDutilh and one of the Life Sciences seminar's initiators - says he was "very happy with the in-depth and solution driven panel discussion on affordability of medicines as well as the variety in subjects ranging from product liability to funding alternatives and from licensing to IPOs we handled during the workshops. Succeeding in the life sciences industry depends on so much more than legal matters: it's about drive, strategy, timing and execution, it's about R&D and it's about reputation and perception. So it was really great to talk about many of those issues with all these leading experts."